An
Angelini Pharma
Rome ITFounded 19193,000 employees
Private CappharmaPrivateCNSInfectious Disease
Platform: CNS Anti-infect
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ANG-192 | ANG-192 | Phase 3 | 1 | CD47 | MMSCD | ||
| ANG-3408 | ANG-3408 | Phase 2/3 | 2 | BCL-2 | PSPMCL |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)